<i>In Vitro</i> Assessment of the Effects of Anti-HER2 Monoclonal Antibodies on Proliferation of HER2-Overexpressing Breast Cancer Cells

Abstract

Our findings indicate that combination of some stimulatory mAbs could completely abolish the inhibitory effect of other mAbs against HER2. Employment of some combinations of mAbs with significant synergistic inhibitory function may improve the therapeutic efficacy of HER2-specific mAbs.